Moolec Science SA (MLEC)
NASDAQ: MLEC · Real-Time Price · USD
0.850
-0.005 (-0.58%)
Nov 21, 2024, 12:54 PM EST - Market open
Moolec Science Income Statement
Financials in millions USD. Fiscal year is July - June.
Millions USD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Dec '20 Dec 31, 2020 |
Revenue | 5.63 | 5.63 | 0.91 | - | - | - |
Revenue Growth (YoY) | 521.53% | 521.53% | - | - | - | - |
Cost of Revenue | 5.15 | 5.15 | 1.05 | - | - | - |
Gross Profit | 0.47 | 0.47 | -0.14 | - | - | - |
Selling, General & Admin | 7.76 | 7.76 | 5.06 | 2.63 | 1.8 | 0.42 |
Research & Development | 1.77 | 1.77 | 1.35 | 0.99 | 1.2 | 0.54 |
Other Operating Expenses | -0.02 | -0.02 | 0.1 | 0.04 | 0.19 | 0.01 |
Operating Expenses | 9.52 | 9.52 | 49.22 | 3.65 | 3.19 | 0.96 |
Operating Income | -9.04 | -9.04 | -49.36 | -3.65 | -3.19 | -0.96 |
Interest Expense | -1.17 | -1.17 | -0.16 | -0 | - | - |
Interest & Investment Income | 1.39 | 1.39 | 0.69 | - | - | - |
Earnings From Equity Investments | - | - | - | - | -0.78 | - |
Currency Exchange Gain (Loss) | -3.42 | -3.42 | -1.39 | -0.01 | - | - |
Other Non Operating Income (Expenses) | 3.35 | 3.35 | 0.71 | -0.86 | - | - |
EBT Excluding Unusual Items | -8.89 | -8.89 | -49.5 | -4.53 | -3.97 | -0.96 |
Merger & Restructuring Charges | - | - | -3.54 | - | - | - |
Gain (Loss) on Sale of Investments | 0.53 | 0.53 | 1.01 | - | - | - |
Pretax Income | -8.36 | -8.36 | -52.02 | -4.53 | -3.97 | -0.96 |
Income Tax Expense | -1.05 | -1.05 | -0.23 | - | - | - |
Net Income | -7.31 | -7.31 | -51.79 | -4.53 | -3.97 | -0.96 |
Net Income to Common | -7.31 | -7.31 | -51.79 | -4.53 | -3.97 | -0.96 |
Shares Outstanding (Basic) | 38 | 38 | 34 | 31 | 30 | 29 |
Shares Outstanding (Diluted) | 38 | 38 | 34 | 31 | 30 | 29 |
Shares Change (YoY) | 9.88% | 9.88% | 11.18% | 2.51% | 3.77% | - |
EPS (Basic) | -0.19 | -0.19 | -1.50 | -0.15 | -0.13 | -0.03 |
EPS (Diluted) | -0.19 | -0.19 | -1.50 | -0.15 | -0.13 | -0.03 |
Free Cash Flow | -9.49 | -9.49 | -7.53 | -1.89 | 1.96 | -7.8 |
Free Cash Flow Per Share | -0.25 | -0.25 | -0.22 | -0.06 | 0.06 | -0.27 |
Gross Margin | 8.40% | 8.40% | -15.83% | - | - | - |
Operating Margin | -160.76% | -160.76% | -5453.72% | - | - | - |
Profit Margin | -129.99% | -129.99% | -5722.22% | - | - | - |
Free Cash Flow Margin | -168.65% | -168.65% | -831.58% | - | - | - |
EBITDA | -8.16 | -8.16 | -49.24 | -3.65 | - | - |
EBITDA Margin | -145.00% | -145.00% | - | - | - | - |
D&A For EBITDA | 0.89 | 0.89 | 0.12 | 0 | - | - |
EBIT | -9.04 | -9.04 | -49.36 | -3.65 | -3.19 | -0.96 |
EBIT Margin | -160.76% | -160.76% | - | - | - | - |
Source: S&P Capital IQ. Standard template. Financial Sources.